Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Is ‘Getting More Aggressive’ In Going After Drug Efficacy Claims Outside Label
Dec 06 2023
•
By
Brenda Sandburg
FDA is giving greater scrutiny to prescription drug promotions that overstate efficacy • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Marketing & Advertising
More from Compliance